These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7025775)

  • 1. Cardiovascular effects of intravenous tolmesoxide in hypertensive patients.
    Scheen A; Luyckx AS; De Graeve J
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):322-34. PubMed ID: 7025775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of tolmesoxide on certain cardiovascular measurements in healthy human volunteers [proceedings].
    Buylla JA; Clifford JM; Wynne RD
    Br J Clin Pharmacol; 1979 Oct; 8(4):402P. PubMed ID: 508540
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives.
    Elliott HL; Meredith PA; McLean K; Hughes MA; Reid JL
    Eur J Clin Pharmacol; 1982; 21(4):287-91. PubMed ID: 7056273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical pharmacology of vasodilator antihypertensive drugs.
    O'Malley K; O'Boyle C; Kelly JG; McNay JL; O'Brien ET
    Arch Int Pharmacodyn Ther; 1980; Suppl():95-103. PubMed ID: 7416880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man.
    Collier JG; Lorge RE; Robinson BF
    Br J Clin Pharmacol; 1978 Jan; 5(1):35-44. PubMed ID: 413560
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle.
    Doxey JC
    Br J Pharmacol; 1978 May; 63(1):111-8. PubMed ID: 647155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
    Taylor AA; Mangoo-Karim R; Ballard KD; Luther RR; Pool JL
    J Clin Pharmacol; 1999 May; 39(5):471-9. PubMed ID: 10234594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of tolmesoxide in refractory heart failure.
    O'Boyle CP; McGarry K; Fitzgerald D; Kelly JG; Horgan J; O'Malley K
    Eur J Clin Pharmacol; 1981; 21(3):169-72. PubMed ID: 7318877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J; Mondot S; Montier F; Cavero I
    J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic and metabolic effects of tolmesoxide with special reference to impaired myocardial function.
    Mackenzie JE; Marshall RJ; Parratt JR
    Br J Pharmacol; 1986 Oct; 89(2):313-9. PubMed ID: 3779213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
    Sanjuliani AF; Fagundes VG; Francischetti EA
    Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of dihydralazine diazoxide and minoxidil alone or associated with propranolol in renal hypertensive rats.
    Provost Y; Lindenbaum A; Cohen Y; Wepierre J
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):103-15. PubMed ID: 7259363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
    Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pressor, renal and endocrine effects of systemic infusion of L-arginine in hypertensive patients].
    Dell'Omo G; Catapano G; Ebel M; Gazzano A; Ducci M; Del Chicca M; Clerico A; Pedrinelli R
    Ann Ital Med Int; 1995; 10(2):107-12. PubMed ID: 7619649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide.
    Mullie A; Lust P; Nievel J; Penninckx J; Vanhove L; Van Hoonacker G; Vendevelde K; Fenwick J; Coghill J
    Acta Anaesthesiol Belg; 1980; 31 Suppl():147-54. PubMed ID: 7457056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamics and metabolic parameters during use of the antihypertensive agent diazoxide].
    Drobny H; Preuss EG; Seige K
    Z Gesamte Inn Med; 1978 Dec; 33(23):856-61. PubMed ID: 741829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.